BioAI Announces Strategic Partnership with Arbele Bio to advance Predictive AI-Models in Oncology Clinical Trials

PM and health minister reach agreement with drug company for ‘tens of thousands of doses’; initial data shows almost 90% efficacy Pfizer has pledged a shipment of its experimental antiviral COVID-19 pill to Israel, according to a Saturday...

DeepBio said its DeepDx-Prostate Pro, an artificial intelligence (AI)-based pathology diagnosis assistance software, has received a Class 3 in-vitro diagnostic medical device from the Ministry of Food and Drug Safety. According to the...

10 - 14 November 2021 In-Person and Online Booth 209 The team at Indica Labs would like to invite you to stop by booth #209 at SITC to learn more about the latest in our HALO®, HALO AI™, HALO Link™, and HALO AP® image analysis...

AI and manual pathology measurements show efficacy of semaglutide over placebo in phase 2 clinical trial, with AI continuous scoring providing quantitative insight into histological changes Boston, Massachusetts - PathAI, a global leader of...

SAN JOSE, Calif., Nov. 9, 2021 /PRNewswire/ -- OptraSCAN® , a leading end-to-end digital pathology solution provider announces its partnership with Inspirata Inc., a leading provider of digital pathology and cancer informatics...

Vancouver, British Columbia - Motic, a leading provider of digital pathology solutions, today announced that the MoticEasyScan product line of Whole Slide Scanners obtained a Health Canada Class II Medical Device License. MoticEasyScan...